Servier Expands Base4 Partnership to Advance Neuroscience Drug Development
Improving the lives of our patients
We work tirelessly to deliver meaningful therapeutic progress to the patients we serve.
Servier Expands Base4 Partnership to Advance Neuroscience Drug Development
Nicolas Garnier joins Servier as Chief Patient Officer
Data at ASH 2023 Underscores Servier Leadership in Hard-to-Treat Hematologic Malignancies